Cochrane · systematic review · CD013280

Indocyanine green angiography for preventing postoperative mastectomy skin flap necrosis in immediate breast reconstruction

Pruimboom, T, Schols, RM, Van Kuijk, SMJ, et al. · Cochrane Database of Systematic Reviews · 2020 · Cochrane Library

Breast CancerAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
12
current version
GRADE rated
11
No studies
1
Included studies
NR
No studies 1 · 8.3%Ungraded 0 · 0%Very low 11 · 91.7%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Indocyanine Green Angiography (ICGA) compared to clinical evaluation for preventing complications (on a per patient basis) in immediate breast reconstruction following mastectomy.

Population: women undergoing immediate breast reconstruction following mastectomy
6 questions
OutcomeEffectEvidenceStatus / GRADE
Mastectomy skin flap necrosis (number of women with mastectomy skin flap necrosis within 30 days after surgery)
Indocyanine Green Angiography (ICGA) vs clinical evaluation
RR 0.79 [0.4, 1.56]3 studies · 573 participantsVery low
Downgraded: imprecision
Reoperation (number of women that were operated again within 30 days after surgery)
Indocyanine Green Angiography (ICGA) vs clinical evaluation
RR 0.5 [0.35, 0.72]4 studies · 613 participantsVery low
Downgraded: imprecision
Dehiscence (number of women with dehiscence within 30 days after surgery).
Indocyanine Green Angiography (ICGA) vs clinical evaluation
RR 4 [0.45, 35.45]1 study · 368 participantsVery low
Downgraded: imprecision
Infection (number of women with infection of the skin flap or implant within 30 days after surgery)
Indocyanine Green Angiography (ICGA) vs clinical evaluation
RR 0.91 [0.6, 1.4]4 studies · 613 participantsVery low
Downgraded: imprecision
Haematoma (number of women with haematoma within 30 days after surgery)
Indocyanine Green Angiography (ICGA) vs clinical evaluation
RR 0.87 [0.3, 2.53]2 studies · 459 participantsVery low
Downgraded: imprecision
Seroma (number of women with seroma within 30 days after surgery)
Indocyanine Green Angiography (ICGA) vs clinical evaluation
RR 1.68 [0.41, 6.8]2 studies · 408 participantsVery low
Downgraded: imprecision

Indocyanine Green Angiography (ICGA) compared to clinical evaluation for preventing complications (on a per breast basis) in immediate breast reconstruction following mastectomy.

Population: women undergoing immediate breast reconstruction following mastectomy
6 questions
OutcomeEffectEvidenceStatus / GRADE
Mastectomy skin flap necrosis (number of breasts with mastectomy skin flap necrosis within 30 days after surgery)
Indocyanine Green Angiography (ICGA) vs clinical evaluation
RR 0.62 [0.48, 0.82]NRVery low
Downgraded: imprecision
Reoperation (number of breasts that needed to be operated again within 30 days after surgery)
Indocyanine Green Angiography (ICGA) vs clinical evaluation
RR 0.65 [0.47, 0.92]NRVery low
Downgraded: imprecision
Dehiscence ‐ not reported
Indocyanine Green Angiography (ICGA) vs clinical evaluation
no estimate extractedNRNo studies
Infection (number of breasts with infection within 30 days after surgery)
Indocyanine Green Angiography (ICGA) vs clinical evaluation
RR 0.65 [0.44, 0.97]NRVery low
Downgraded: imprecision
Haematoma (number of breasts with haematoma within 30 days after surgery)
Indocyanine Green Angiography (ICGA) vs clinical evaluation
RR 1.53 [0.47, 4.95]NRVery low
Downgraded: imprecision
Seroma (number of breast with seroma within 30 days after surgery)
Indocyanine Green Angiography (ICGA) vs clinical evaluation
RR 0.71 [0.37, 1.35]NRVery low
Downgraded: imprecision